NicOx S.A.

Research NicOx S.A. (ALCOX) on Bullrun: market cap EUR 32.43M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerALCOX
• ExchangePA
• CountryFrance
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 32.43M
• Financial periodFY2024
• RevenueEUR 7.86M
• Revenue growth13.8%
• Net income-EUR 22.39M
• Gross margin85.9%

Valuation Snapshot

latest market cap is EUR 32.43M.

About NicOx S.A.

Nicox S.A., together with its subsidiaries, operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve eye health. The company's lead product candidate is NCX 470, a novel nitric oxide (NO)-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in Phase 3 clinical trial.

Frequently asked questions

What is NicOx S.A.'s market cap?

NicOx S.A.'s market capitalization is EUR 32.43M.

What does NicOx S.A. do?

Nicox S.A., together with its subsidiaries, operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve eye health.